Literature DB >> 10224154

Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilizing the Genome Reporter Matrix.

D Dimster-Denk1, J Rine, J Phillips, S Scherer, P Cundiff, K DeBord, D Gilliland, S Hickman, A Jarvis, L Tong, M Ashby.   

Abstract

Gene expression profiling is rapidly becoming a mainstay of functional genomic studies. However, there have been relatively few studies of how the data from expression profiles integrate with more classic approaches to examine gene expression. This study used gene expression profiling of a portion of the genome of Saccharomyces cerevisiae to explore the impact of blocks in the isoprenoid biosynthetic pathway on the expression of genes and the regulation of this pathway. Approximately 50% of the genes whose expression was altered by blocks in isoprenoid biosynthesis were genes previously known to participate in the pathway. In contrast to this simple correspondence, the regulatory patterns revealed by different blocks, and in particular by antifungal azoles, was complex in a manner not anticipated by earlier studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224154

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  25 in total

1.  Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol.

Authors:  G F Bammert; J M Fostel
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Identification of azole-responsive genes by microarray technology: why are we missing the efflux transporter genes?

Authors:  D P Kontoyiannis; G S May
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray.

Authors:  M D De Backer; T Ilyina; X J Ma; S Vandoninck; W H Luyten; H Vanden Bossche
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Chemogenomic profiling: identifying the functional interactions of small molecules in yeast.

Authors:  Guri Giaever; Patrick Flaherty; Jochen Kumm; Michael Proctor; Corey Nislow; Daniel F Jaramillo; Angela M Chu; Michael I Jordan; Adam P Arkin; Ronald W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

5.  Mod5 protein binds to tRNA gene complexes and affects local transcriptional silencing.

Authors:  Matthew Pratt-Hyatt; Dave A Pai; Rebecca A Haeusler; Glenn G Wozniak; Paul D Good; Erin L Miller; Ian X McLeod; John R Yates; Anita K Hopper; David R Engelke
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

6.  ROX1 and ERG regulation in Saccharomyces cerevisiae: implications for antifungal susceptibility.

Authors:  Karl W Henry; Joseph T Nickels; Thomas D Edlind
Journal:  Eukaryot Cell       Date:  2002-12

7.  Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action.

Authors:  Maureen E Hillenmeyer; Elke Ericson; Ronald W Davis; Corey Nislow; Daphne Koller; Guri Giaever
Journal:  Genome Biol       Date:  2010-03-12       Impact factor: 13.583

8.  Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering.

Authors:  Dwight Kuo; Kai Tan; Guy Zinman; Timothy Ravasi; Ziv Bar-Joseph; Trey Ideker
Journal:  Genome Biol       Date:  2010-07-23       Impact factor: 13.583

9.  Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae.

Authors:  Cintia Hongay; Nan Jia; Martin Bard; Fred Winston
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

10.  Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.

Authors:  Pooja Jain; Indira Akula; Thomas Edlind
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.